Table of contents

Extended reports

• EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (7 October, 2004)

  W Zhang, M Doherty, N Arden, B Bannwarth, J Bijlsma, K-P Gunther, H J Hauselmann, G Herrero-Beaumont, K Jordan, P Kaklamanis, B Leeb, M Lequesne, S Lohmander, B Mazieres, E Martin-Mola, K Pavelka, A Pendleton, L Punzi, B Swoboda, R Varatojo, G Verbruggen, I Zimmermann-Gorska, M Dougados
• Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study) (16 September, 2004)

  S Dahaghin, S M A Bierma-Zeinstra, A Z Ginai, H A P Pols, J M W Hazes, B W Koes
• A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs (4 November, 2004)

  V Rabenda, N Burlet, O Ethgen, F Raeman, J Belaiche, J-Y Reginster
• MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis (15 April, 2005)

  I Tchetverikov, L S Lohmander, N Verzijl, T W J Huizinga, J M TeKoppele, R Hanemaaijer, J DeGroot
• Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas (4 February, 2005)

  P Geborek, A Bladström, C Turesson, A Gulfe, I F Petersson, T Saxne, H Olsson, L T H Jacobsson
• Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis (14 October, 2004)

  G J Wolbink, A E Voskuyl, W F Lems, E de Groot, M T Nurmohamed, P P Tak, B A C Dijkmans, L Aarden
• Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium (21 October, 2004)

  S Rosengren, H M Hoffman, W Bugbee, D L Boyle
• Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis (7 October, 2004)

  R Goldbach-Mansky, S Suson, R Wesley, C E Hack, H S El-Gabalawy, P P Tak
• Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis (11 November, 2004)

  J Zou, H Appel, M Rudwaleit, A Thiel, J Sieper
• Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging (30 September, 2004)

  X Baraliakos, R Landewé, K-G Hermann, J Listing, W Golder, J Brandt, M Rudwaleit, M Bollow, J Sieper, D van der Heijde, J Braun
• Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal (15 April, 2005)

  S-M Dai, Z-Z Shan, K Nishioka, K Yudoh
• Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis (30 September, 2004)

  M Schaller, W Stohl, S M Tan, V M Benoit, D M Hilbert, H J Ditzel
• E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever (30 September, 2004)

  R Topaloglu, F Ozaltin, E Yilmaz, S Ozen, B Balci, N Besbas, A Bakkaloglu
• Accelerated atherosclerosis in patients with Wegener’s granulomatosis (16 September, 2004)

  K de Leeuw, J-S Sanders, C Stegeman, A Smit, C G Kallenberg, M Bijl
• Exercises versus arthroscopic decompression in patients with subacromial impingement: a randomised, controlled study in 90 cases with a one year follow up (15 April, 2005)

  J P Haahr, S Østergaard, J Dalsgaard, K Norup, P Frost, S Lausen, E A Holm, J H Andersen